(Q38175843)

30 August 2017

0 references

Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients (English)

1 reference

30 August 2017

0 references

1 reference

1 reference

Meng-Bo Hu

1

1 reference

30 August 2017

Hua Xu

2

1 reference

30 August 2017

Pei-De Bai

3

1 reference

30 August 2017

Hao-Wen Jiang

4

1 reference

30 August 2017

Qiang Ding

5

1 reference

30 August 2017

publication date

5 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

31

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

829

1 reference

Health and economic burden of the projected obesity trends in the USA and the UK.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Cytokine and endocrine signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Anterior perirectal fat tissue thickness is a strong predictor of recurrence after high-intensity focused ultrasound for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Association of body mass index with prostate cancer biochemical failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Influence of body mass index and total testosterone level on biochemical recurrence following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Predicting blood loss and transfusion requirements during radical prostatectomy: the significant negative impact of increasing body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Testosterone as a predictor of pathological stage in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0829-8

Impact of Body Mass Index on Outcomes After Conformal Radiotherapy in Patients With Prostate Cancer

21 January 2018

1 reference

12 December 2020

Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?

1 reference

12 December 2020

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

1 reference

12 December 2020

Obesity and survival after radical prostatectomy: A 10-year prospective cohort study

1 reference

12 December 2020

Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix con

1 reference

12 December 2020

Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer

1 reference

12 December 2020

Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

1 reference

12 December 2020

Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images

1 reference

12 December 2020

Radical prostatectomy in obese patients: Improved surgical outcomes in recent years

1 reference

12 December 2020

Obesity Is Not Associated With Aggressive Pathologic Features or Biochemical Recurrence After Radical Prostatectomy

1 reference

12 December 2020

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

1 reference

12 December 2020

Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy

1 reference

12 December 2020

10.1007/S12032-013-0829-8

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1004884372

0 references

1 reference